Silver Oak Securities Incorporated Acquires 557 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Silver Oak Securities Incorporated lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,878 shares of the healthcare conglomerate’s stock after purchasing an additional 557 shares during the quarter. Silver Oak Securities Incorporated’s holdings in UnitedHealth Group were worth $1,462,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Elm3 Financial Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth $403,000. State of Alaska Department of Revenue boosted its holdings in shares of UnitedHealth Group by 9.9% in the 4th quarter. State of Alaska Department of Revenue now owns 129,471 shares of the healthcare conglomerate’s stock worth $65,493,000 after purchasing an additional 11,620 shares in the last quarter. Caitlin John LLC raised its holdings in shares of UnitedHealth Group by 17.7% during the 4th quarter. Caitlin John LLC now owns 751 shares of the healthcare conglomerate’s stock valued at $380,000 after buying an additional 113 shares in the last quarter. YANKCOM Partnership bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $1,095,000. Finally, Vision Capital Management Inc. bought a new stake in shares of UnitedHealth Group in the 4th quarter worth approximately $272,000. 87.86% of the stock is currently owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent research reports. Bank of America lowered their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. Truist Financial reduced their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Piper Sandler lowered their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $529.71 on Friday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $487.48 billion, a PE ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company’s fifty day moving average price is $532.43 and its 200-day moving average price is $564.77. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the business earned $5.83 earnings per share. The business’s revenue was up 6.8% on a year-over-year basis. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.